Ventas (VTR): financials, SEC filings and peers
Ventas (VTR) is a health care reits company in the Real Estate sector of the S&P 500, headquartered in Chicago, Illinois.
It was founded in 1998 and joined the S&P 500 on March 4, 2009.
Its fiscal year ends in December, and its shares trade on the NYSE.
In its SEC filings it is classified as “Real Estate Investment Trusts”.
Ventas at a glance
- Revenue (12 months)
- $6.8B
- Revenue growth
- +22.1%
- Operating margin
- 12.5%
- Net income (12 months)
- $272M
- Free cash flow (12 months)
- —
- Cash
- $202M
- Debt
- —
- Diluted EPS (12 months)
- $0.52
Twelve months to September 30, 2026, from the 10-Q filed October 28, 2026.
Latest twelve months
Over the twelve months to September 30, 2026, Ventas reported revenue of $6.8 billion, up 22.1% from a year earlier.
Its operating margin was 12.5%: for every $100 of sales, about $13 was left as operating profit.
Net income was $272 million (4.0% of revenue), 9.8% higher than a year earlier.
At the end of the period it held $202 million in cash and not reported in debt, a net cash position of $202 million.
The diluted share count rose 12.0% in a year, which dilutes existing shareholders.
Five-year trend
- Revenue went from $3.8 billion in fiscal 2020 to $5.8 billion in fiscal 2025, about 9.0% a year.
- Revenue has grown for 5 fiscal years in a row.
- Free cash flow was negative in 3 of the last 6 fiscal years.
- Ventas reported a net loss in 2 of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.8B | $4.1B | $4.5B | $4.9B | $5.8B |
| Revenue growth | 0.9% | 7.9% | 8.9% | 9.5% | 18.5% |
| Operating margin | — | — | — | — | — |
| Net income | $57M | −$41M | −$30M | $88M | $262M |
| Free cash flow | −$776M | $219M | $470M | −$1.2B | −$1.3B |
| Diluted EPS | $0.13 | $-0.12 | $-0.10 | $0.19 | $0.54 |
Fiscal years as reported in Ventas’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 8-K filed November 10, 2026 — Other event
- 10-Q filed October 28, 2026 — quarterly report
- 8-K filed October 27, 2026 — Earnings results
- 8-K filed September 15, 2026 — Executive or director change
- 10-Q filed July 30, 2026 — quarterly report
- 8-K filed July 29, 2026 — Earnings results
- 8-K filed June 15, 2026 — Executive or director change; Other event
- 8-K filed May 15, 2026 — Executive or director change; Shareholder vote results
Companies like Ventas
Other S&P 500 companies in Health Care REITs:
More from Real Estate
Questions about Ventas
Is Ventas's revenue growing?
Yes. Revenue for the twelve months to September 30, 2026 was $6.8 billion, up 22.1% from a year earlier, according to its SEC filings.
Is Ventas profitable?
Yes. It earned $272 million in net income over the twelve months to September 30, 2026, a net margin of 4.0%.
When did Ventas last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on October 28, 2026.
Which companies are similar to Ventas?
In the S&P 500, Ventas is grouped in Health Care REITs within the Real Estate sector. Healthpeak Properties (DOC), Welltower (WELL) are in the same group.
Understand the numbers
Source: Ventas’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.